reteplase (Retevase)
Jump to navigation
Jump to search
Introduction
Tradename: Retevase.
Indications
acute myocardial infarction
Dosage
- 10.8 units IV over 2 minutes
- repeat dose in 30 minutes
- for use with unfractionated heparin or LMW heparin
Adverse effects
Mechanism of action
- plasminogen activator
- retavase is a fragment of tissue plasminogen activator that contains kringle 2 & the protease domain
More general terms
References
- ↑ Physician's Desk Reference (PDR) 54th edition, Medical Economics, 2000
- ↑ Jump up to: 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17. American College of Physicians, Philadelphia 2009, 2012, 2015